Exploring the Predicting Biomarkers From Mild Cognitive Impairment to Dementia (EBMID)

RecruitingOBSERVATIONAL
Enrollment

900

Participants

Timeline

Start Date

February 28, 2023

Primary Completion Date

February 28, 2028

Study Completion Date

February 28, 2028

Conditions
BiomarkersMCI Conversion to Dementia
Trial Locations (1)

100053

RECRUITING

Xuan Wu Hospital of Capital Medical University, Beijing

All Listed Sponsors
lead

Cuibai Wei,Clinical Professor

OTHER

collaborator

Beihang University

OTHER

collaborator

Chinese PLA General Hospital

OTHER

collaborator

Chongqing Medical University

OTHER

collaborator

Tianjin Huanhu Hospital

OTHER

collaborator

Affiliated Zhongshan Hospital of Dalian University

OTHER

collaborator

First Hospital of Shijiazhuang City

OTHER

collaborator

Jilin University

OTHER

NCT05697588 - Exploring the Predicting Biomarkers From Mild Cognitive Impairment to Dementia (EBMID) | Biotech Hunter | Biotech Hunter